PDS Biotechnology Corp filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-14. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: James Banaag, Director
Mr. Banaag was appointed as a Class A director of the Company, to serve until the Company's 2028 annual meeting of stockholders or until his earlier death, resignation, removal, or until such time that Nant no longer has the right to designate two Nant Designees pursuant to the terms and conditions of the Purchase Agreement.
Appointed: Janetta Trochimiuk, President and Chief Executive Officer, effective 2026-09-12
On August 19, 2026, the board of directors of the Company appointed Janetta Trochimiuk, the Company's Controller, as interim Principal Accounting Officer and Frank Bedu-Addo, Ph.D., the Company's President and Chief Executive Officer, as interim Principal Financial Officer, each effective as of September 12, 2026.
Find people with the same kind of experience as the Director at PDS Biotechnology Corp, with the record behind each one.
Find candidates like Director at PDS Biotechnology CorpNew leaders review vendors and budgets in their first months. Get an alert the next time PDS Biotechnology Corp is in the news or changes leadership.
Get an alert when PDS Biotechnology Corp changes leadershipTools for this story
Each opens in a new tab, filled in for PDS Biotechnology Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.